STAT3 and liver cancer: In recent years, an increasing number of studies have revealed that the IL-6/STAT3 signaling pathway plays a pivotal role in the development of liver cancer, and many studies have shown that inhibition of the IL-6/STAT3 signaling pathway can block the occurrence and progress of HCC.